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Skin is the major tissue where melanocytes develop,
and skin keratinocytes provide the necessary micro-
environment for melanocyte survival, proliferation,
differentiation, and migration. In this paper, we will
discuss the ligands for receptor tyrosine kinases pro-
duced as environmental cues to support melanocyte
development in the skin. Key words: melanocytes/
skin/receptor tyrosine kinase/steel factor/c-Kit/hepatocyte
growth factor. Journal of Investigative Dermatology
Symposium Proceedings 6:6±9, 2001
R
eceptor tyrosine kinases play important roles in
many aspects of developmental processes, includ-
ing those of the melanocyte cell lineage (Molleman
and Halaban, 1998; Hirobe et al, 1999). c-Kit is the
most extensively studied receptor tyrosine kinase
in melanocyte precursors (melanoblasts); it is essential for the
survival, growth, differentiation, and migration of melanoblasts. Its
ligand, known as steel factor (hereafter called SLF, also named SCF,
MGF, or KL), is produced by mesenchymal cells or keratinocytes
(Wehrle-Haller and Weston, 1999) and stimulates c-Kit expressed
on melanoblasts. As expected, mice with defects of the c-Kit or
SLF gene develop a white or white spot phenotype caused
by a complete lack or decrease of melanoblasts (Barsh, 1996).
Dependency of melanoblast development on c-Kit is well
conserved even in zebla®sh (Parichy et al, 1999), suggesting that
molecular mechanisms of melanocyte development are evolution-
arily conserved. Considering the obvious fact that melanocytes are
an integrated component of the skin tissue, environmental cues
including ligands for receptor tyrosine kinases must be utilized to
maintain homeostasis of the skin system. In addition, these ligands
may have a unique importance for understanding diseases related to
melanocyte development.
WHAT KINDS OF RECEPTORS ARE EXPRESSED IN
THE DEVELOPING MELANOCYTES?
Previous studies demonstrated expression of receptor tyrosine
kinases in normal human melanocytes (Lee et al, 1993). To avoid
the signi®cant disregulation of gene expression in vitro cultures, we
investigated the expression of receptor tyrosine kinases in normal
melanoblasts puri®ed from neonatal skin. Reverse transcriptase-
polymerase chain reaction (RT-PCR) and sequencing analysis
revealed expression of four receptor tyrosine kinases known to
affect melanocyte lineage cells (Fig 1). Fibroblast growth factor
(FGF) receptor and insulin receptor are essential for various cell
types, and serum-free cultures of melanocytes require these two
factors (Hirobe, 1992). c-Kit is the receptor for SLF, which is
known to be an essential factor for melanocyte development, as
described above. c-Met, the receptor for hepatocyte growth factor
(HGF), is also known to induce proliferation of cultured human
melanocytes (Matsumoto et al, 1991). Considering the ubiquitous
expression of these receptors and the dependency on the ligands,
FGF and insulin might not have melanocyte-speci®c functions.
The role of c-met in melanocyte development has not been studied
genetically because mutant mice that lack HGF or c-met are
embryonic lethal around 13.5 dpc, possibly due to an essential
function in organogenesis. The analysis of our limited number of
RT-PCR-based cDNA clones suggests that novel receptor tyrosine
kinases may not be expressed in developing melanoblasts.
SURVIVAL, PROLIFERATION, MIGRATION, OR
DIFFERENTIATION: WHAT ARE THE ROLES OF
LIGANDS FOR RECEPTOR TYROSINE KINASES IN
MELANOCYTE DEVELOPMENT?
As developmental processes proceed seamlessly, classi®cation of the
developmental processes into function-based categories is not so
simple. For example, proliferation without survival is nonsense, and
differentiation without proliferation occurs in some cases, but
usually cells become differentiated while proliferating. In fact, as
discussed by other authors (Galli et al, 1993), SLF may contribute to
every phase of cell development, including survival, proliferation,
migration, and differentiation. In the case of melanocyte lineage
cells, SLF supports their survival and proliferation of the neural crest
cells prepared from isolated neural tubes (Murphy et al, 1992;
Morrison-Graham and Weston, 1993). In vivo administration of
SLF to human skin induced pigmented spots in situ, suggesting the
promotion of proliferation and differentiation of melanocytes by
SLF (Grichnik et al, 1995).
In mouse skin, in contrast to human skin, melanocytes or their
precursors cease growing after birth and disappear during the ®rst
month of life except in hair follicles (Hirobe, 1984). When
expression of SLF was forced in the skin using transgenic mice,
melanocytes continued to reside in the epidermis of the skin.
Accordingly, the skin was densely pigmented throughout life.
Apparently, SLF together with the in vivo skin environment
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promotes survival and proliferation of melanocytes or their
precursors (Kunisada et al, 1998a). Exogenous SLF does not simply
promote proliferation of mature melanocytes, because unpigmen-
ted TRP2-positive and c-Kit-positive melanoblasts were observed
in the epidermis of SLF transgenic skin. In addition, regions that no
melanocytes normally reach at any stage of development, such as
the oral epithelium and the tooth gum, were heavily pigmented in
SLF transgenic mice, suggesting that SLF has the ability to stimulate
migration of melanoblasts (Kunisada et al, 1998b). The expression
pattern of SLF as related to possible effects on melanocytes and
experimentally observed biological effects of SLF on melanocyte
development are summarized in Table I.
By the same strategy of inducing ectopic expression of the ligand
molecule in transgenic mice, HGF was also found to be able to
promote survival, proliferation, and differentiation of melanocytes
(Kunisada et al 2000). The function of ectopic HGF in melanocytes
overlapped considerably with that of SLF.
In these two cases, the possibility that these ligands for receptor
tyrosine kinases act only to stimulate the growth of melanocytes
was clearly ruled out; however, at least in the skin of laboratory
mice, mature fully pigmented melanocytes are rarely observed,
except in hair follicles and unhaired skin such as ears, lips, or
external genitalia. In the transgenic animals described above, a
number of mature melanocytes were detected as early as the
newborn stage, indicating that a single ligand molecule could
change the skin environment so as to support survival, proliferation,
and differentiation of melanocytes. If the ligands stimulate only
survival and proliferation, the skin should be occupied by
undifferentiated melanoblasts instead of pigmented melanocytes.
Although indirect effects of these ligands, e.g., via keratinocytes, are
possible, it is still true that the ligand-furnished skin environment
supports survival, proliferation, differentiation, and in case of SLF,
migration of melanocyte lineage cells.
An interesting difference was also observed between these two
kinds of transgenic mice. Most of the melanocytes were observed in
the basal layer of the epidermis, where the cytokeratin promoter
directs the transgene expression, as expected, in the case of SLF
transgenic mice (Kunisada et al, 1998a, b). In contrast, melanocytes
were mostly located in the dermis in all three independent lines of
HGF transgenic mice (Kunisada et al, 2000), whereas immunohis-
tochemical analysis con®rmed epidermal expression of HGF
molecules in the transgenic skin. The ligand molecules might
have the more subtle regulatory function as to where in the skin
melanocytes should be located. Interestingly, the ear of the normal
mouse, in which dermal melanocytes are the major population,
expressed a higher level of HGF mRNA than haired skin,
suggesting that the dermal melanocytes induced by HGF might
not be an extreme case caused by the abnormal skin environment
affected by the ectopic expression of HGF.
RELATIONSHIP OF THE SIGNALING BY STEEL
FACTOR OR HGF WITH THE SIGNALING MEDIATED
BY ENDOTHELIN 3
Endothelin 3 (ET3) is one of the essential factors for the early
development of melanocytes. Mice with ET3 mutations (lethal
spotted, ls/ls, Baynash et al, 1994) or mutations of its G-protein-
coupled receptor, endothelin receptor-B (piebald lethal, sl/sl,
Hosoda et al, 1994) show similar white spots, indicating the
essential function of ET3 for melanocyte development. By using
the tetracycline induction system in vivo, the critical period when
melanocytes depend on ET3 was determined to extend from 10.5
dpc to 12.5 dpc (Shin et al, 1999). Even gene-targeted null mutants
of ET3 and endothelin receptor-B mice do not completely lose
their melanocytes, suggesting that ET3 signaling might not be
indispensable for survival and/or growth of melanoblasts, but rather
required for their migration. In fact, the migration activity of
melanoblasts is most prominent during 10.5±13.5 dpc (Yoshida et al,
1996). In ls/ls mice, melanoblasts appear as early as 10.5 dpc, but
stay in the head and tail regions until 13.5 dpc, and then start to
migrate and ®nally cover most of the coat, except for the trunk
region (Yoshida et al, 1996). After 13.5 dpc, SLF may act or
compensate for the ET3 activity for melanoblast migration. ET3
stimulates proliferation and differentiation of melanocytes, at least
in vitro, as does SLF (Lahav et al, 1996; Reid et al, 1996). Even in the
presence of ET3, the function-blocking antibody for c-Kit
completely abolishes the generation of melanocytes, indicating
that ET3 and c-Kit are independently required for the survival
and/or proliferation of melanocyte lineage cells (Yoshida et al,
unpublished observation). ET3 might affect another phase of
melanocyte differentiation, because melanocytes cultured in the
presence of ET3 are excessively pigmented and highly dendritic in
shape compared with the melanocytes induced by SLF (Lahav et al,
1996). Another unique function of ET3 is the induction of glial cell
precursors from fully mature melanocytes (Dupin et al, 2000). This
Figure 1. Receptor tyrosine kinases expressed in the skin
melanocyte precursors. (A) Dorsal trunk skin was prepared from
newborn C57BL/6 mice. After pieces of skin were washed three times
with phosphate-buffered saline (PBS), they were incubated in PBS
containing 0.25% trypsin, and then epidermal sheets were pealed off and
dissociated in the presence of 0.02%EDTA, as described in detail by
Hirobe (1992). The epidermal cells harvested were then resuspended in
Hanks' balanced salt solution containing 10% rabbit serum, and stained
with PE-conjugated anti-c-Kit antibody (ACK4) and FITC-conjugated
anti-CD45 antibody as described by Kunisada et al (1996). After sorting
the c-Kit + CD45-fraction enclosed by the broken line, the cells were
pelleted and total cellular RNA was puri®ed using ISOGEN. The purity
of the sorted cells was more than 95%, as assessed by the re-analysis by
¯ow cytometry. (B) Two micrograms of isolated RNA was used to
perform reverse transcription using odigo dT primers, and 1/10 of the
reaction was used for the PCR reaction by using degenerate primers
PTKI and PTKII as detailed in Ogawa et al (1998). Ampli®ed DNA
fragments were puri®ed by agarose gel electrophoresis, cloned into
PCR2.1 vector and sequenced. A total of 60 clones containing protein
kinase sequences were analyzed to determine their nucleotide sequences
and identities.
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unusual change of cell lineage is a phenomenon known as trans-
differentiation. Whether SLF or HGF play a role in this trans-
differentiation caused by ET3 is not known.
ROLES OF LIGAND MOLECULES IN THE
DEVELOPMENT OF MELANOMAS
The development of cancer is closely associated with normal
differentiation pathways. Therefore, factors that act in the course of
normal development may provide keys to understanding mechan-
isms of neoplastic transformation, in this case, transformation to
melanomas. When HGF is expressed in the whole body under the
control of a metallothionein promoter sequence, melanocyte
occurs in both the dermis and the epidermis (Takayama et al,
1997). In addition, tumors, including melanomas, are frequently
observed. Metallothionein may induce HGF expression in all cells
including melanocytes themselves, and an autocrine loop formed
between c-Met expressed in melanocytes is then essential for
neoplastic transformation. In contrast, in k14-HGF transgenic
mice, melanomas and other tumors are rarely observed. In this type
of transgenic mouse, HGF is supplied only from keratinocytes. The
mode of ligand supply, autocrine or paracrine, may determine the
fate of melanocytes. Alternatively, it is possible that the crucial
point is not the mode of the ligand supply but the amount of the
ligand; in other words, the metallothionein promoter may simply
produce more ligand molecules. We currently do not favor this
possibility, because the extent of pigmentation and the number of
melanocytes in the skin are comparable in these two types of
transgenic mice, indicating that the amount of HGF produced and
the amount of signaling through c-Met may not be very different.
Furthermore, the serum concentration of HGF in metallothionein-
HGF transgenic mice is 16 ng per ml (Takayama et al, 1996) and
that in k14-HGF transgenic mice is 10 ng per ml (unpublished
observations). In k14-SLF transgenic mice, no signi®cant mela-
noma development has been observed during more than 6 years of
their maintenance (Kunisada et al, unpublished observation). These
observations support the idea that it is not the amount of HGF
produced in the local environment, but rather the mode of ligand
supply, that is important for malignant transformation.
A QUESTION THAT WE COULD NOT ANSWER
One of the prominent features of melanocytes is their strong ability
to migrate and eventually cover the whole body. This in turn raises
the question of why melanocytes cover the whole body without
accumulating in the most distal parts such as the belly or tail. The
mechanism enabling the uniform distribution of melanocytes might
be a yet unknown and important feature of melanocytes. Targeted
expression of SLF in the basal layer of the skin actually extended
melanocyte distribution; still, melanocytes seemed to be evenly
distributed. In this case of k14-SLF transgenic mice, melanoblasts of
14.5 dpc embryos were observed to occupy the oral epithelium,
suggesting that melanocyte precursors have an intrinsic tendency to
migrate under the suitable environment. The simple assumption
that some melanoblasts are not migratory and some are extremely
migratory may explain the even distribution of melanocytes
throughout the skin. More precisely, the presence or maintenance
of more immature, more migratory melanoblasts is the ®rst
requisite. The existence of such melanocyte stem cells is suggested
by the phenomenon of adult hair regeneration. In each hair cycle,
not only keratinocytes but also melanocytes were regenerated from
a small number of stem cells. No direct evidence of melanocyte
stem cells is available, but the presence of these cells is suggested by
the fact that putative melanocyte stem cells in the adult hair follicles
are maintained in a c-Kit-independent manner (Nishikawa et al,
1991). Segregation or maintenance of a small number of
Table I. Summary of expression of SLF and biologic effects of SLF on melanocyte development
Type of experiments Main conclusions about melanocyte development Reference
In situ hybridization SLF transcripts are present in the ectoderm of whisker follicles, around the otic vesicle, developing
ear and dermis (but not the epidermis).
Matsui et al, 1990
In situ hybridization Expression of SLF in developing dermal skin at least from E13.0. Later in development,
SLF expression decreases markedly.
Keshet et al, 1991
lacZ activity in
transgenic mice
SLF expression in embryonic dermal skin and dermal papillae of hair follicles was veri®ed using
SLF promoter-lacZ transgenic mice.
Yoshida et al, 1996
In vitro administration
of recombinant SLF
Normal human melanocytes proliferate in vitro when SLF is provided with PMA, but SLF alone
has little effect. In the ®ve of eight human melanomas tested, c-Kit was not constitutively
hybridization activated.
Funasaka et al, 1992
In vitro administration
of recombinant SLF
In contrast to the effects on normal melanocytes, SLF inhibited rather than stimulated the
growth of metastatic melanoma cell lines.
Zact et al, 1993
In vitro administration
of recombinant SLF
Random chemokinetic movement of cultured melanocytes was induced by SLF in vitro, and also
by basic ®broblast growth factor, leukotriene C4, and endothelin-1.
Horikawa et al, 1995
In vitro administration
of recombinant SLF
SLF supported the maintenance of melanoblasts but did not stimulate their ®nal maturation. Murphy et al, 1992
In vitro administration
of recombinant SLF
SLF acts primarily as a survival factor for melanoblasts derived from cultured neural crest cells.





Survival and proliferation of c-kit+TRP2+ melanoblasts but not other lineages were observed
in mouse cultured neural crest cells.





Implanted SLF beads did not stimulate melanoblast migration towards the bead, rather melanocyte






Targeted expression of SLF in mouse skin promoted survival, proliferation, differentiation, and
migration of melanocyte precursors.
Kunisada et al, 1998b
In vivo administration
of recombinant SLF
Skin at the site of SLF injection (14 d of 5 mg per kg) had an increased number of melanocytes,
increased melanocytic dendrite extension, and increased melanin.
Grichnik et al, 1995
In vivo administration
of recombinant SLF
Daily application of r-hSLF induced hyperpigmentation at least during the initial 14 d of
administration. In humans, r-hSLF-induced hypermelanosis occurs before the onset of
melanocytic hyperplasia.
Costa et al, 1996
In vivo administration
of recombinant SLF
Human skin xenografts treated with r-hSLF showed increased number, size, and dendricity
of melanocytes.
Grichnik et al, 1998
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melanocyte stem cells is assumed to occur during proliferation and
differentiation of melanoblasts. In a colony derived from
melanocyte stem cells, at least one cell is maintained as a stem
cell, and later this cell migrates away and forms a new colony. In
any case, ligands for receptor tyrosine kinases play essential roles in
the migration of melanoblasts in vivo, as indicated by the
experiments involving ectopic expression of the ligands. Some
diseases characterized by hypo- or hyper-pigmentation may
presumably be a manifestation of altered receptor tyrosine kinase
signaling, which stimulates the migration of melanocyte lineage
cells.
FUTURE PROSPECTS
Recently, a different type of secreted factors, Wnt family proteins,
were reported to affect melanocyte differentiation, at least in
zebra®sh (Dorsky et al, 1998). In zebra®sh, Wnt is used to select the
neural crest cell fate to either neuronal cells or melanocytes. There
must be additional environmental factors that regulate melanocyte
development, and searching for these molecules is important in
order to fully understand the early developmental processes of
melanocyte lineages. The link between the signals from receptor
tyrosine kinases and transcription factors controlling melanocyte
development is still uncertain. It was reported that MITF, a basic-
helix-loop-helix-zipper transcription factor, alone could induce
NIH3T3 cells to develop into melanocytes (Tachibana et al, 1996).
c-Kit signaling may cause phosphorylation of MITF through a
MAP kinase pathway (Goding, 2000). At least in cultured mast
cells, MITF could also induce c-Kit expression. In any case, MITF
is currently the only known transcription factor that leads to
expression of melanocyte-speci®c genes.
We thank Dr. Kowichi Jimbow for providing us the opportunity to write this paper.
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